The problems with polypharmacy
Polypharmacy, or the concomitant use of multiple medicines, is estimated to cost $18 billion and account for 8.6 million hospital admissions annually in the European Union. The iSIMPATHY […]
Polypharmacy, or the concomitant use of multiple medicines, is estimated to cost $18 billion and account for 8.6 million hospital admissions annually in the European Union. The iSIMPATHY […]
With the outbreak of the Pandemic and the lingering worries of COVID-19 pharmaceutical sales and marketing has taken a hit. There are no live conferences that health care […]
In a randomized clinical trial published in the journal PAIN, researchers found participants with moderate to severe irritable bowel syndrome (IBS) who were knowingly treated with a pharmacologically inactive […]
The European Medicines Agency gave its backing to 15 new medicines at its December meeting, taking its total for the year to 96. This rounded off a busy […]
Researchers at Massachusetts Institute of Technology (MIT) have developed an artificial intelligence (AI) model that can distinguish between asymptomatic people with covid-19 and healthy individuals. One of the […]
Testing for malaria could become as simple as putting on a bandage. That’s the idea behind a platform developed by Rice University engineers who introduced a microneedle patch […]
Pharmacist Anita Hogg explains how well Medicines Optimisation Innovation Centre (MOIC) model to estimate the critical care drug requirements during the covid-19 pandemic worked and the lessons learned […]
Pharmacist Anita Hogg explains how the Medicines Optimisation Innovation Centre (MOIC) in Belfast developed and applied a model to estimate the critical care drug requirements during the covid-19 […]
Pharmacist Anita Hogg explains the work of the Medicines Optimisation Innovation Centre (MOIC) in Belfast and how the Centre helped to ensure reliable provision of critical care drugs […]
Research undertaken by RCSI University of Medicine and Health Sciences suggests that integrating pharmacists into general practice (GP) teams facilitates collaboration to optimise treatment plans for patients with […]
Practice pharmacists were able to adjust and simplify drug treatment to ensure continued effective treatment during the covid pandemic – and could do more of this type of […]
Two programmes comprising training materials and back-up resources, have been essential for the development of effective practice pharmacy services that deliver meaningful benefits in primary care, according to […]